Beacon Therapeutics has secured more than $75 million in Series C financing to advance the...
NEWS
Waterborne disease poses a growing global threat as water...
Waterborne disease is emerging as a significant and growing public health threat across both...
Breast cancer remains the world’s most-studied disease area in...
Phesi has published its latest annual analysis of global clinical development activity, based on...
Bayer receives Breakthrough Therapy Designation for sevabertinib...
Bayer has received Breakthrough Therapy Designation in the United States and China for sevabertinib...